NDC codes

375325 NDC codes with hospital pricing data in the network.

• NDC 69315028401 — ESTERIFIED ESTROGENS-METHYLTESTOSTERONE 1.25 MG-2.5 MG TABLET (12 hospitals, 10,670–10,859 samples)
• NDC 50633022004 — uridine triacetate 10 gram Grpk 4 Each Packet (14 hospitals, 10,670–10,859 samples)
• NDC 09991382600 — SULFAMETHOXAZOLE 0.04 MG-TMP 0.008 MG/ML ORAL SUSP (DESENSITIZATION) (SOLN B) (12 hospitals, 10,670–10,859 samples)
• NDC 72603026201 — Pyrimethamine (13 hospitals, 10,670–10,859 samples)
• NDC 72603031310 — VELETRI 1.5 MG IV SOLR (17 hospitals, 10,670–10,859 samples)
• NDC 09991381100 — METRONIDAZOLE 2.5 MG/ML ORAL SUSPENSION (DESENSITIZATION) (12 hospitals, 10,670–10,859 samples)
• NDC 70710117903 — ambrisentan 5 mg Tab (28 hospitals, 10,670–10,859 samples)
• NDC 24338000690 — THYROID (PORK) 30 MG TABLET (13 hospitals, 10,670–10,859 samples)
• NDC 31722005460 — ivabradine HCl 7.5 MG tablet 60 each Bottle (19 hospitals, 10,670–10,859 samples)
• NDC 00469286001 — ISAVUCONAZONIUM SULFATE 74.5 MG CAPSULE (16 hospitals, 10,670–10,859 samples)
• NDC 72162207202 — Propylthiouracil (13 hospitals, 10,670–10,859 samples)
• NDC 09991381000 — METRONIDAZOLE 0.25 MG/ML ORAL SUSPENSION (DESENSITIZATION) (12 hospitals, 10,670–10,859 samples)
• NDC 68180015209 — mirabegron (13 hospitals, 10,670–10,859 samples)
• NDC 72162179009 — Morphine Sulfate (13 hospitals, 10,670–10,859 samples)
• NDC 00480706256 — Perampanel: 30 Tablet, Film Coated In 1 Bottle (0480-7062-56) (18 hospitals, 10,670–10,859 samples)
• NDC 52536050003 — DEXTROAMPHETAMINE SULFATE 5 MG TABLET (15 hospitals, 10,670–10,859 samples)
• NDC 09991380900 — METRONIDAZOLE 0.025 MG/ML ORAL SUSPENSION (DESENSITIZATION) (12 hospitals, 10,670–10,859 samples)
• NDC 00469286035 — ISAVUCONAZONIUM SULFATE 74.5 MG CAPSULE (20 hospitals, 10,670–10,859 samples)
• NDC 72603028502 — ATORVASTATIN 80 MG TABLET (13 hospitals, 10,670–10,859 samples)
• NDC 72789045730 — Cevimeline HCl (13 hospitals, 10,670–10,859 samples)
• NDC 09991382500 — SULFAMETHOXAZOLE 0.004 MG-TMP 0.0008 MG/ML ORAL SUSP (DESENSITIZATION) (SOLUTION A) (12 hospitals, 10,670–10,859 samples)
• NDC 00703-4246-01 — CARBOPLATIN 10 MG/ML DESENSITIZATION (118 hospitals, 10,784–10,829 samples)
• NDC 17478-0082-90 — ROPIVACAINE PER 1 MG (33 hospitals, 9,027–10,827 samples)
• NDC 00006-3026-02 — PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION (129 hospitals, 10,489–10,813 samples)
• NDC 39822303001 — NDC Description Not Available (75 hospitals, 9,599–10,805 samples)
• NDC 00409426411 — HYDROMORPHONE 0.5 MG/0.5 ML INJECTION WRAPPER (158 hospitals, 4,089–10,794 samples)
• NDC 00409177805 — METOPROLOL TARTRATE 1MG(5MG) (179 hospitals, 10,016–10,790 samples)
• NDC 00487278401 — racEPINEPHrine 2.25% Inh 0.5 mL (124 hospitals, 10,077–10,788 samples)
• NDC 00093317431 — ALBUTEROL SULFATE INHAL AERO 108 MCG/ACT (90MCG BASE EQUIV) (114 hospitals, 9,576–10,764 samples)
• NDC 00143-9701-01 — IRINOTECAN 100 MG/5 ML IV SOLN (80 hospitals, 10,694–10,748 samples)
• NDC 00409-2308-01 — MIDAZOLAM (PF) 5 MG/ML INJECTION SOLUTION (109 hospitals, 10,218–10,740 samples)
• NDC 65219047405 — SODIUM CHLORIDE 0.9 % IV (PVC FREE) (21 hospitals, 10,550–10,739 samples)
• NDC 00409115901 — BUPIVACAINE HCL (PF) 0.25 % IJ SOLN (234 hospitals, 4,938–10,734 samples)
• NDC 70121-1573-01 — METHYLPREDNISOLONE ACETATE 40 MG/ML SUSPENSION FOR INJECTION (110 hospitals, 10,684–10,720 samples)
• NDC 00169-7501-11 — INSULIN ASPART U-100 100 UNIT/ML SUBCUTANEOUS SOLUTION (111 hospitals, 10,484–10,709 samples)
• NDC 00409131203 — HYDROMORPHONE 2 MG/ML INJECTION SYRINGE (147 hospitals, 4,080–10,704 samples)
• NDC 43066-0015-10 — ROPivacaine 0.2% 20 mL amp inj. (31 hospitals, 10,606–10,696 samples)
• NDC 43598013074 — METHYLPREDNISOLONE SODIUM SUCC 1000 MG IJ SOLR CUSTOM (169 hospitals, 6,375–10,695 samples)
• NDC 00904-6084-61 — CITALOPRAM 10 MG TABLET (141 hospitals, 10,307–10,685 samples)
• NDC 00409116201 — bupivacaine 0.5% *PF* inj 10 mL (234 hospitals, 4,993–10,672 samples)
• NDC 00002-8824-27 — INSULIN REGULAR HUMAN (CONC) 500 UNIT/ML SC SOPN (57 hospitals, 10,484–10,637 samples)
• NDC 57894-0503-01 — DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN (192 hospitals, 10,041–10,635 samples)
• NDC 00054317763 — Dexamethasone: 500 Ml In 1 Bottle, Plastic (0054-3177-63) (127 hospitals, 8,453–10,604 samples)
• NDC 76297000142 — sodium chloride 0.9% (13 hospitals, 10,395–10,584 samples)
• NDC 00409115902 — BUPIVACAINE (PF) 0.25 % (2.5 MG/ML) INJECTION SOLUTION (245 hospitals, 4,969–10,567 samples)
• NDC 63323-0106-02 — MAGNESIUM SULFATE IN WATER 2 GRAM/50 ML (4 %) IV PGBK (95 hospitals, 10,433–10,559 samples)
• NDC 00173087414 — ARNUITY ELLIPTA 100 MCG/ACTUATION IN DSDV (175 hospitals, 9,600–10,554 samples)
• NDC 63323026910 — PROPOFOL 100 MG/10ML IV EMUL (183 hospitals, 7,212–10,551 samples)
• NDC 67457043710 — 67457-0437-10 - doxycycline 100 mg Powder (143 hospitals, 9,793–10,540 samples)
• NDC 00597010051 — TIOTROPIUM BROMIDE MONOHYDRATE 2.5 MCG/ACT IN AERS (176 hospitals, 9,591–10,536 samples)